
United States · Medical devices startup
Medical 21, Inc. is a developmental-stage medical device company based in Minneapolis.
Funding reportedLast round: Undisclosed round
Medical 21, Inc. is a developmental-stage medical device company based in Minneapolis.
The company focuses on enhancing coronary artery bypass surgery through innovative technologies, including an artificial graft and regenerative vascular conduit. Its primary product, the MAVERICS coronary graft, is designed to bypass blockages in the heart, offering an alternative to traditional vessel harvesting. Medical 21 aims to make heart bypass surgery safer, less painful, and more cost-effective, ultimately improving patient quality of life. The company is led by Manny Villafaña, who serves as Founder, Chairman, and CEO.
Funding, as reported
Medical 21, Inc. filed one raise, $4.0M in all. Filings say how much was sold and to how many investors; they never name the investors.
What they build
Known for
vascular regeneration technologyhealth carebiocompatible graftblood vessel replacementsurgical innovationcardiac bypassmanufacturingcardiac bypass surgerymedical researchheart disease solutionsvascular regenerationcardiovascular healthmedical device innovationsynthetic blood vesselbiocompatible materialshospital & health care
Built with from their website
Google Tag Managerparallax.jsSquarespace ECommerceWordPress.orgON24Viewport MetaElement UIPriority HintsGoogle Font APIMagento 2
Microsoft ExchangeMySQLMicrosoft 365 Apps & ServicesMobile FriendlyMagento Open SourceOpen GraphRSSSquarespace
Add your raise, your deck and your story, and put Medical 21, Inc. in front of investors. Or tell us what we have wrong.